Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.

Hu WY, Shi GB, Hu DP, Nelles JL, Prins GS.

Mol Cell Endocrinol. 2012 May 6;354(1-2):63-73. doi: 10.1016/j.mce.2011.08.032. Epub 2011 Sep 5. Review.

2.

Stem Cells as Hormone Targets That Lead to Increased Cancer Susceptibility.

Prins GS, Calderon-Gierszal EL, Hu WY.

Endocrinology. 2015 Oct;156(10):3451-7. doi: 10.1210/en.2015-1357. Epub 2015 Aug 4.

3.

Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells.

Hu WY, Shi GB, Lam HM, Hu DP, Ho SM, Madueke IC, Kajdacsy-Balla A, Prins GS.

Endocrinology. 2011 Jun;152(6):2150-63. doi: 10.1210/en.2010-1377. Epub 2011 Mar 22.

4.

Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients.

Rachoń D.

Rev Endocr Metab Disord. 2015 Dec;16(4):359-64. doi: 10.1007/s11154-016-9332-9. Review.

5.

Actions of endocrine-disrupting chemicals on stem/progenitor cells during development and disease.

Kopras E, Potluri V, Bermudez ML, Williams K, Belcher S, Kasper S.

Endocr Relat Cancer. 2014 Mar 12;21(2):T1-12. doi: 10.1530/ERC-13-0360. Print 2014 Apr. Review.

6.

Bisphenol A promotes human prostate stem-progenitor cell self-renewal and increases in vivo carcinogenesis in human prostate epithelium.

Prins GS, Hu WY, Shi GB, Hu DP, Majumdar S, Li G, Huang K, Nelles JL, Ho SM, Walker CL, Kajdacsy-Balla A, van Breemen RB.

Endocrinology. 2014 Mar;155(3):805-17. doi: 10.1210/en.2013-1955. Epub 2014 Jan 1.

7.

Developmental exposure to endocrine disrupting chemicals alters the epigenome: Identification of reprogrammed targets.

Prusinski L, Al-Hendy A, Yang Q.

Gynecol Obstet Res. 2016 Jul;3(1):1-6. Epub 2016 May 3.

8.

Influence of neonatal estrogens on rat prostate development.

Prins GS, Birch L, Habermann H, Chang WY, Tebeau C, Putz O, Bieberich C.

Reprod Fertil Dev. 2001;13(4):241-52.

PMID:
11800163
9.

Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life.

Newbold RR.

Am J Clin Nutr. 2011 Dec;94(6 Suppl):1939S-1942S. doi: 10.3945/ajcn.110.001057. Epub 2011 Nov 16.

10.

Hypothesis: Activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer.

Treviño LS, Wang Q, Walker CL.

Reprod Toxicol. 2015 Jul;54:136-40. doi: 10.1016/j.reprotox.2014.12.014. Epub 2014 Dec 29. Review.

11.

The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity.

Vom Saal FS, Nagel SC, Coe BL, Angle BM, Taylor JA.

Mol Cell Endocrinol. 2012 May 6;354(1-2):74-84. doi: 10.1016/j.mce.2012.01.001. Epub 2012 Jan 10. Review.

12.

Endocrine-disrupting chemical exposure and the American alligator: a review of the potential role of environmental estrogens on the immune system of a top trophic carnivore.

Finger JW Jr, Gogal RM Jr.

Arch Environ Contam Toxicol. 2013 Nov;65(4):704-14. doi: 10.1007/s00244-013-9953-x. Epub 2013 Sep 20.

PMID:
24051988
13.

Endocrine disruptors and prostate cancer risk.

Prins GS.

Endocr Relat Cancer. 2008 Sep;15(3):649-56. doi: 10.1677/ERC-08-0043. Epub 2008 Jun 4. Review.

14.

Endocrine disruption of the epigenome: a breast cancer link.

Knower KC, To SQ, Leung YK, Ho SM, Clyne CD.

Endocr Relat Cancer. 2014 Mar 12;21(2):T33-55. doi: 10.1530/ERC-13-0513. Print 2014 Apr. Review.

15.
16.

Developmental estrogen exposures predispose to prostate carcinogenesis with aging.

Prins GS, Birch L, Tang WY, Ho SM.

Reprod Toxicol. 2007 Apr-May;23(3):374-82. Epub 2006 Oct 24. Review.

17.

Endocrine disrupting chemicals as potential risk factor for estrogen-dependent cancers.

Rutkowska AZ, Szybiak A, Serkies K, Rachoń D.

Pol Arch Med Wewn. 2016 Aug 9;126(7-8):562-70. doi: 10.20452/pamw.3481. Epub 2016 Aug 9. Review.

18.

Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.

Hotchkiss AK, Rider CV, Blystone CR, Wilson VS, Hartig PC, Ankley GT, Foster PM, Gray CL, Gray LE.

Toxicol Sci. 2008 Oct;105(2):235-59. doi: 10.1093/toxsci/kfn030. Epub 2008 Feb 16. Review.

19.

Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome.

Wong RL, Walker CL.

Clin Cancer Res. 2013 Jul 15;19(14):3732-7. doi: 10.1158/1078-0432.CCR-13-0021. Epub 2013 Apr 2.

20.

Environmental endocrine disruptors: Effects on the human male reproductive system.

Sweeney MF, Hasan N, Soto AM, Sonnenschein C.

Rev Endocr Metab Disord. 2015 Dec;16(4):341-57. doi: 10.1007/s11154-016-9337-4. Review.

Supplemental Content

Support Center